Veru ROE 2010-2025 | VERU
Current and historical return on equity (ROE) values for Veru (VERU) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Veru ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.04B | $0.02B | -125.42% |
| 2024-12-31 | $-0.04B | $0.03B | -109.86% |
| 2024-09-30 | $-0.04B | $0.03B | -91.02% |
| 2024-06-30 | $-0.04B | $0.04B | -95.48% |
| 2024-03-31 | $-0.04B | $0.05B | -113.04% |
| 2023-12-31 | $-0.06B | $0.05B | -229.09% |
| 2023-09-30 | $-0.09B | $0.02B | -351.40% |
| 2023-06-30 | $-0.13B | $0.02B | -298.82% |
| 2023-03-31 | $-0.14B | $0.02B | -204.51% |
| 2022-12-31 | $-0.12B | $0.05B | -120.52% |
| 2022-09-30 | $-0.08B | $0.08B | -68.60% |
| 2022-06-30 | $-0.05B | $0.12B | -33.27% |
| 2022-03-31 | $-0.03B | $0.14B | -18.27% |
| 2021-12-31 | $-0.02B | $0.15B | -10.49% |
| 2021-09-30 | $0.01B | $0.15B | 5.48% |
| 2021-06-30 | $0.00B | $0.16B | -1.03% |
| 2021-03-31 | $0.00B | $0.16B | -1.45% |
| 2020-12-31 | $0.00B | $0.05B | 2.65% |
| 2020-09-30 | $-0.02B | $0.03B | -57.58% |
| 2020-06-30 | $-0.01B | $0.04B | -29.85% |
| 2020-03-31 | $-0.01B | $0.03B | -31.25% |
| 2019-12-31 | $-0.01B | $0.03B | -39.69% |
| 2019-09-30 | $-0.01B | $0.03B | -34.78% |
| 2019-06-30 | $-0.02B | $0.04B | -50.37% |
| 2019-03-31 | $-0.02B | $0.03B | -64.71% |
| 2018-12-31 | $-0.02B | $0.04B | -61.54% |
| 2018-09-30 | $-0.02B | $0.03B | -63.58% |
| 2018-06-30 | $-0.02B | $0.04B | -49.41% |
| 2018-03-31 | $-0.01B | $0.04B | -30.27% |
| 2017-12-31 | $-0.01B | $0.05B | -24.49% |
| 2017-09-30 | $-0.01B | $0.05B | -17.65% |
| 2017-06-30 | $-0.01B | $0.05B | -12.63% |
| 2017-03-31 | $0.00B | $0.05B | -9.14% |
| 2016-12-31 | $0.00B | $0.05B | -5.06% |
| 2016-09-30 | $0.00B | $0.03B | 0.00% |
| 2016-06-30 | $0.00B | $0.04B | 8.63% |
| 2016-03-31 | $0.00B | $0.04B | 8.89% |
| 2015-12-31 | $0.01B | $0.04B | 15.27% |
| 2015-09-30 | $0.01B | $0.03B | 16.00% |
| 2015-06-30 | $0.00B | $0.03B | 10.00% |
| 2015-03-31 | $0.00B | $0.03B | 10.26% |
| 2014-12-31 | $0.00B | $0.03B | 3.51% |
| 2014-09-30 | $0.00B | $0.03B | 3.51% |
| 2014-06-30 | $0.01B | $0.03B | 30.77% |
| 2014-03-31 | $0.01B | $0.03B | 31.30% |
| 2013-12-31 | $0.01B | $0.03B | 42.48% |
| 2013-09-30 | $0.02B | $0.03B | 55.56% |
| 2013-06-30 | $0.02B | $0.03B | 63.37% |
| 2013-03-31 | $0.02B | $0.03B | 76.60% |
| 2012-12-31 | $0.02B | $0.02B | 80.00% |
| 2012-09-30 | $0.02B | $0.02B | 82.05% |
| 2012-06-30 | $0.01B | $0.02B | 73.24% |
| 2012-03-31 | $0.01B | $0.02B | 62.50% |
| 2011-12-31 | $0.01B | $0.02B | 52.46% |
| 2011-09-30 | $0.01B | $0.02B | 33.90% |
| 2011-06-30 | $0.01B | $0.01B | 41.38% |
| 2011-03-31 | $0.01B | $0.01B | 42.11% |
| 2010-12-31 | $0.01B | $0.02B | 58.18% |
| 2010-09-30 | $0.01B | $0.02B | 53.85% |
| 2010-06-30 | $0.00B | $0.01B | 24.49% |
| 2010-03-31 | $0.00B | $0.01B | 33.33% |
| 2009-12-31 | $0.00B | $0.01B | 34.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.087B | $0.017B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $215.166B | 25.24 |
| Boston Scientific (BSX) | United States | $153.330B | 38.38 |
| Stryker (SYK) | United States | $148.630B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $131.070B | 0.00 |
| Medtronic (MDT) | Ireland | $114.929B | 16.29 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.764B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.126B | 24.61 |
| ResMed (RMD) | United States | $37.818B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $34.781B | 16.51 |
| Agilent Technologies (A) | United States | $32.381B | 21.11 |
| Terumo (TRUMY) | Japan | $23.911B | 31.06 |
| Koninklijke Philips (PHG) | Netherlands | $23.688B | 16.62 |
| Insulet (PODD) | United States | $20.003B | 78.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.437B | 11.84 |
| Baxter (BAX) | United States | $14.251B | 10.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.214B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.705B | 23.33 |
| Lantheus Holdings (LNTH) | United States | $4.855B | 12.25 |
| Prestige Consumer Healthcare (PBH) | United States | $3.744B | 16.73 |
| Perrigo (PRGO) | Ireland | $3.706B | 9.39 |
| Haemonetics (HAE) | United States | $3.485B | 15.88 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.307B | 27.48 |
| ICU Medical (ICUI) | United States | $3.014B | 22.23 |
| LeMaitre Vascular (LMAT) | United States | $1.802B | 40.29 |
| QuidelOrtho (QDEL) | United States | $1.721B | 11.84 |
| AtriCure (ATRC) | United States | $1.449B | 0.00 |
| Acuren (TIC) | United States | $1.408B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Phibro Animal Health (PAHC) | United States | $1.192B | 15.24 |
| Green Thumb Industries (GTBIF) | United States | $1.190B | 26.76 |
| Neogen (NEOG) | United States | $1.029B | 13.17 |
| BioLife Solutions (BLFS) | United States | $0.996B | 0.00 |
| InMode (INMD) | Israel | $0.878B | 8.85 |
| Kestra Medical Technologies (KMTS) | United States | $0.816B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.625B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.619B | 0.00 |
| Owens & Minor (OMI) | United States | $0.599B | 4.97 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.563B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Surmodics (SRDX) | United States | $0.432B | 0.00 |
| SNDL (SNDL) | Canada | $0.405B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.315B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.314B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.298B | 10.97 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.267B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.63 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.50 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.235B | 10.68 |
| Sanara MedTech (SMTI) | United States | $0.234B | 0.00 |
| Brainsway (BWAY) | Israel | $0.228B | 60.45 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| Canopy Growth (CGC) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.199B | 0.00 |
| Omeros (OMER) | United States | $0.197B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.195B | 0.00 |
| Organigram Global (OGI) | Canada | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 14.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.174B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.149B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.80 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 14.52 |
| Nephros (NEPH) | United States | $0.039B | 52.07 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |